Prevention of low-dose acetylsalicylic acid-associated gastric/duodenal ulcers with esomeprazole 20mg and 40mg once daily in patients at increased risk of ulcer development: A randomised controlled trial (Oberon)

Simple item page
dc.contributor.authorScheiman J
dc.contributor.authorVan Rensburg CJ
dc.contributor.authorUebel P
dc.contributor.authorDouda L
dc.contributor.authorNiezgoda K
dc.contributor.authorNauclér E
dc.contributor.authorSvedberg L
dc.date.accessioned2012-08-10T17:42:45Z
dc.date.available2012-08-10T17:42:45Z
dc.date.issued2009
dc.descriptionPlease help us populate SUNScholar with the post print version of this article. It can be e-mailed to: scholar@sun.ac.za
dc.descriptionGeneeskunde
dc.descriptionInterne Geneeskunde
dc.identifier.urihttp://hdl.handle.net/10019.1/41046
dc.titlePrevention of low-dose acetylsalicylic acid-associated gastric/duodenal ulcers with esomeprazole 20mg and 40mg once daily in patients at increased risk of ulcer development: A randomised controlled trial (Oberon)
dc.typeProceedings International
Files
Collections
2009 - Research Outputs